نتایج جستجو برای: 177lu dotatate
تعداد نتایج: 1456 فیلتر نتایج به سال:
177Lu-DOTA-HH1 (177Lu-HH1) is a novel anti-CD37 radioimmunoconjugate developed to treat non-Hodgkin lymphoma. Mice with subcutaneous Ramos xenografts were treated with different activities of 177Lu-HH1, 177Lu-DOTA-rituximab (177Lu-rituximab) and non-specific 177Lu-DOTA-IgG1 (177Lu-IgG1) and therapeutic effect and toxicity of the treatment were monitored. Significant tumor growth delay and incre...
Abstract BACKGROUND While most meningiomas are considered benign tumors, a subset of these tumors characterized by more aggressive clinical course and require multimodal treatment. Beyond surgical radiotherapeutic options, there no effective medical treatments available. Somatostatin receptor 2 (SSTR2) is expressed the majority meningiomas. 177Lu-DOTATATE SSTR2-targeting radionuclide that has b...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید